Cancer plaintiffs drill down on J&J's support for $8.9 bln talc deal

Posted on:
Key Points

NEW YORK, June 28 (Reuters) - The lead negotiators for Johnson & Johnson's proposed $8.9 billion settlement of thousands of talc lawsuits faced intense questioning in U.S. bankruptcy court on Wednesday about how much support the company has for the deal...

During a multi-day court hearing in Trenton, New Jersey, attorneys for plaintiffs alleging that J&J's baby powder and other talc products sometimes contained asbestos and caused ovarian cancer and mesothelioma drilled down on J&J's public statements that it has "secured commitments from over 60,000 current claimants" for the settlement, and that the "majority" of talc claimants support it...

The deal has divided lawyers representing cancer victims, many of whom claim that J&J has created the illusion of widespread support for a settlement that would deny plaintiffs just compensation...

Moshe Maimon, an attorney for cancer victims opposed to the settlement, said that four law firms represent a majority of the 60,000 claims counted by J&J, and he pointed out that none of those firms' clients have yet agreed to support the deal...

Jim Murdica, J&J's outside counsel and lead negotiator on the settlement, defended J&Js public statements and disagreed when Maimon suggested that Watts clients should not be counted as supporters..

You might be interested in

US judge halts most talc lawsuits against Johnson & Johnson, stops trials

21, Apr, 23

A US judge halted roughly 38,000 talc lawsuits consolidated in a federal district court in New Jersey. He allowed other cases to proceed with depositions and other matters as long as no trials commence. New lawsuits can also be filed against J&J, the judge said.

J&J rises as $9 bln talc lawsuit settlement eases overhang on unit spinoff

07, Apr, 23

Johnson & Johnson's shares rose nearly 4% in early trading to hit a near two-month high of $164.48 on Wednesday as the company's $8.9 billion offer to settle talc-related lawsuits gained support of thousands of claimants, easing an overhang on its plans to list consumer health unit Kenvue.

J&J effort to resolve talc lawsuits in bankruptcy fails a second time after judge tosses suit

29, Jul, 23

Johnson & Johnson's proposed $8.9bn settlement to resolve tens of thousands of lawsuits over its talc products has been imperilled. US Bankruptcy Judge Michael Kaplan rejected the healthcare company's second attempt to resolve the cases in bankruptcy, stating that financial distress had not forced the company to act. Plaintiffs have lodged mass lawsuits alleging that Johnson & Johnson's baby powder and other talc products caused mesothelioma, ovarian cancer and other cancers.